|
Executive Summary
Europe’s key strategy meeting for vaccine leaders
The vaccine market place is growing by at least 10% per year and is estimated to be worth $10bn by 2010. There are increased funding opportunities in government and NGO partnerships with industry and academia to meet the challenges of emerging diseases. Also the re-emergence of pathogens has meant that old enemies need to be tackled with new solutions. Vaccines are once again big news.
Many companies are seeing the potential in the market and adapting their technologies to fulfil the need of this booming industry. Competition is increasing for all producers but even more so for the suppliers of services, technology and products to the industry. The World Vaccine Congress is your best opportunity to develop the relationships that will make a difference to your business; a difference to your customer’s businesses.
A showcase opportunity
The eighth annual World Vaccine Congress delivers you opportunities to maintain and grow your market share. The world-class agenda and industry leading speakers do not only attract the people that sign the cheques, they also present on business practices and technologies that can improve your bottom line. It provides a sustained, multi-channel marketing solution that will improve your positioning and brand awareness, culminating in ‘face to face’ marketing with your target audience. As the vaccine industry becomes more competitive you cannot afford to lose out to your rivals.
A truly global event
With a world leading agenda and speakers in 2006 you will see even more senior level people from industry, public health and academia gather in Lyon. The agenda will have two streams: one on global access and development strategies and one on practical issues in vaccine development. With the myriad of partnerships that are emerging between governments, NGOs, industry and academia, the congress will bring these sectors together for a true cross-fertilisation of ideas. It will be the place where the global vaccine community meets to map out the future of vaccine development for future generations.
Proven track record
- Terrapinn, established in 1986, runs conferences on every continent
- On average the World Vaccine Congress attracts over 70% Director / VP level attendees
- Successful Pharma brands worldwide include: World Vaccine Congreses Montreal and Lyon; bioLOGIC Europe, USA and Asia.
- Over 220 organisations attended just in 2005
- 24 countries represented across Europe and the rest of the world
- Over 100,000 high quality brochures and flyers to be sent in 2006
- Adverts in the top ten industry publications with your logo on them
|
